Invesco’s Sharps Compliance Corp SMED Stock Holding History

Invesco’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14,664	Closed	-$211K	–	4080
2021 Q1	$211K	Buy	+14,664	New	+$189K	﹤0.01%	3670

Other funds holding SMED

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco's SMED Position: Q2 2021 in Review

Invesco sold out of Sharps Compliance Corp (SMED) in Q2 2021, closing a stake of 14,664 shares — an estimated $211K sold.

Invesco first reported a position in SMED in Q1 2021 and held it in 1 quarter. The position peaked at $211K in Q1 2021. 83 funds tracked by Wall St. Rank hold SMED as of Q2 2021.

Invesco reported no remaining Sharps Compliance Corp position as of Q2 2021 after selling out during the quarter.
Invesco sold 14,664 Sharps Compliance Corp shares in Q2 2021, an estimated $211K.
Invesco first reported a position in Sharps Compliance Corp in Q1 2021 and held it in 1 quarter.
Invesco's Sharps Compliance Corp position peaked at $211K in Q1 2021.
83 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.